NR

Noah Rosenberg

Chief Medical Officer

Verrica Pharmaceuticals

Therapeutic Areas

Verrica Pharmaceuticals Pipeline

DrugIndicationPhase
YCANTH (VP-102)Molluscum ContagiosumApproved
VP-315Basal Cell CarcinomaPhase 2
VP-102External Genital WartsPhase 2
VP-103Plantar WartsPreclinical